Stellate Therapeutics Inc.
PrivateLast Round
VC Round
May 18, 2021
Company Overview
Stellate Therapeutics Inc. is a biotechnology company that develops small molecules produced by human gut bacteria into first-in-class personalized therapies for neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stellate Therapeutics Inc. Comparables
Compare Stellate Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterin | 85% | |
| Vertero Therapeutics | 82% | |
| Holobiome | 74% | |
Stellate Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 18, 2021 |
Stellate Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| eureKARE | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2024
Monthly visitors increased 252% MoM, reaching 327.
- May 18, 2021
Led by eureKARE
Stellate Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stellate Therapeutics Inc.'s valuation, stock price, and market status.